netFormulary The Rotherham NHS
NHS Foundation Trust  
 Search
 Formulary Chapter 8: Malignant disease and immunosuppression - Full Chapter
08.02.03  Expand sub section  Anti-lymphocyte monoclonal antibodies
Alemtuzumab (MabCampath®)
View adult BNF View SPC online View childrens BNF  Track Changes 		Formulary
Red 		Injection 
   
Obinutuzumab (Gazyvaro)
View adult BNF View SPC online View childrens BNF  Track Changes 		Restricted Drug Restricted
Red

Solution for infusion

 
Link  Obinutuzumab with bendamustine for treating follicular lymphoma refractory to rituximab
   
Cytotoxic Drug Rituximab (MabThera®)
View adult BNF View SPC online View childrens BNF  Track Changes 		Formulary
Red 		Injection

Pre-filled syringe (use restricted use)

 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
 Display tracking information
click to search medicines.org.uk
 Link to adult BNF
click to search medicines.org.uk
 Link to children's BNF
click to search medicines.org.uk
 Link to SPCs
SMC
 Scottish Medicines Consortium
Cytotoxic Drug
 Cytotoxic Drug
CD
 Controlled Drug
High Cost Medicine
 High Cost Medicine
Cancer Drugs Fund
 Cancer Drugs Fund
NHSE
 NHS England
Homecare
 Homecare
CCG
 CCG

Traffic Light Status Information

Status Description

Amber

 Medicines that should be initiated or recommended by a specialist for continuation in primary care  

Green

 Medicines suitable for routine use within primary and secondary care  

Red

 Medicines which should normally be prescribed by specialists only  

netFormulary